Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

SEC Mediates m6A Deposition and Transcription Pause Release to Drive Cell Identity Transition.

Created on 07 Oct 2026

Authors

Zhijing Zhang, Jingyi Xu, Yonghong Wu, Yitong Qu, Xinglin Hu, Yuchen Sun, Yanshuang Wu, Zhonghua Liu, Jiaqiang Wang, Lei Lei

Published in

Advanced science (Weinheim, Baden-Wurttemberg, Germany). Pages e78131. Oct 06, 2026. Epub Oct 06, 2026.

Abstract

Induced pluripotent stem cell (iPSC) reprogramming and embryonic stem cell (ESC) differentiation represent opposite models of cell identity transition, yet their regulatory mechanisms remain incompletely understood. Here, we identify the Super Elongation Complex (SEC), the most pivotal regulators of transcription pause release, as a central driver of cell identity transition in both models.
SEC depletion markedly impairs iPSC reprogramming efficiency, particularly during the early stage, by suppressing core reprogramming genes, including Klf4 and Myc, thereby disrupting key reprogramming events, such as cell-cycle progression and activation of the pluripotency network. Mechanistically, SEC activates the expression of Klf4 and Myc by promoting the release of pre-established paused RNA polymerase II (RNA Pol II). Moreover, SEC also cooperates with METTL3 to facilitate N6-methyladenosine (m6A) deposition and transcription pause release at Klf4 and Myc, revealing an additional regulatory layer during iPSC reprogramming. Similarly, during ESC neural induction, SEC upregulates neural gene expression and facilitates ESC transition into the neuroectoderm lineage, via promoting transcription pause release at relevant loci.
These findings establish SEC as a shared regulator of cell identity transition in both iPSC reprogramming and ESC differentiation. Elucidating the mechanisms by which SEC drives cell identity transitions provides a foundation for further investigation into diverse cell identity transitions under physiological and pathological conditions.

PMID:
42839642
Bibliographic data and abstract were imported from PubMed on 07 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement